NCT01164904 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions

Ulcerative Colitis

Interventions

DRUG

Amg 181

Ten escalating dose levels of AMG 181 administered as single dose SC or IV, in healthy volunteers and SC subjects with mild-to-moderate ulcerative colitis.

Trial Locations (10)

1023

Research Site, Auckland

3004

Research Site, Prahran

4006

Research Site, Herston

5000

Research Site, Adelaide

6009

Research Site, Nedlands

8011

Research Site, Christchurch

16635

Research Site, Duncansville

55446

Research Site, Plymouth

91206

Research Site, Glendale

06810

Research Site, Danbury